Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$718K Sell
21,926
-292
-1% -$12K 0.01% 335
2025
Q4
$914K Buy
22,218
+12,124
+120% +$454K 0.02% 282
2025
Q3
$360K Buy
10,094
+4,032
+67% +$122K 0.01% 455
2025
Q2
$329K Buy
+6,062
New +$356K 0.01% 437
2022
Q4
Sell
-126
Closed -$10K 516
2022
Q3
$10K Buy
126
+26
+26% +$2.32K ﹤0.01% 749
2022
Q2
$8K Sell
100
-25
-20% -$2.08K ﹤0.01% 802
2022
Q1
$11K Buy
125
+81
+184% +$6.64K ﹤0.01% 744
2021
Q4
$4K Buy
44
+6
+16% +$440 ﹤0.01% 929
2021
Q3
$2K Hold
38
﹤0.01% 993
2021
Q2
$3K Sell
38
-62
-62% -$4.25K ﹤0.01% 973
2021
Q1
$6K Buy
100
+56
+127% +$3.47K ﹤0.01% 794
2020
Q4
$3K Sell
44
-1,035
-96% -$65.8K ﹤0.01% 809
2020
Q3
$63K Buy
1,079
+1,035
+2,352% +$64.3K 0.01% 331
2020
Q2
$3K Sell
44
-6
-12% -$391 ﹤0.01% 778
2020
Q1
$2.97K Sell
50
-178
-78% -$10.8K ﹤0.01% 729
2019
Q4
$14.3K Buy
228
+44
+24% +$2.39K ﹤0.01% 665
2019
Q3
$7.96K Buy
+184
New +$8.96K ﹤0.01% 879

Other funds holding CNC

Evoke Wealth's CNC Position: Q1 2026 in Review

Evoke Wealth reduced its Centene (CNC) stake by 1.3% in Q1 2026, selling an estimated $12K and leaving 21,926 shares worth $718K. The position accounts for 0.01% of the portfolio, ranked #335.

Evoke Wealth first reported a position in CNC in Q3 2019 and has held it in 17 quarters since. The position peaked at $914K in Q4 2025. 862 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

  • Evoke Wealth held 21,926 shares of Centene worth $718K as of Q1 2026.
  • Evoke Wealth sold 292 Centene shares in Q1 2026, an estimated $12K.
  • Centene made up 0.01% of Evoke Wealth's portfolio in Q1 2026, its #335 holding.
  • Evoke Wealth first reported a position in Centene in Q3 2019 and has held it in 17 quarters since.
  • Evoke Wealth's Centene position peaked at $914K in Q4 2025.
  • 862 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on Evoke Wealth's 13F filing for Q1 2026, filed 15 May 2026.